The structural heart market is projected to grow significantly, reaching an estimated US$ 13,850.2 million by 2025, up from US$ 6,406.3 million in 2017. This growth represents a compound annual growth rate (CAGR) of 10.5% from 2017 to 2025.
Several factors are propelling the growth of the structural heart market, particularly the introduction of innovative structural heart services. The surge in technological advancements has led to numerous innovations in products and treatment services, enabling surgeons, physicians, and healthcare providers to deliver optimal care to their patients. These innovations extend beyond healthcare facilities; they also encompass programs designed to enhance patient experiences and outcomes from treatment options.
However, the market faces challenges, notably the high costs associated with products and procedures, which have hindered growth. Despite this, the ongoing trend of technological advancements in structural heart devices is expected to bolster market expansion during the forecast period.
In terms of product segmentation, the structural heart market is categorized into occluders, annuloplasty rings, heart valve balloons, and other devices. Among these, occluders command the largest market share, while heart valve balloons are recognized as the fastest-growing segment. In 2017, the occluders segment accounted for 42.0% of the market share and is anticipated to maintain its leading position through 2025. Conversely, heart valve balloons contributed 31.2% to the market share in 2017 and are projected to experience the most rapid growth in the near future.
The procedure segment of the structural heart market includes surgical aortic valve replacement, transcatheter aortic valve replacement, mitral repair, left atrial appendage closure, and others. In 2017, the surgical aortic valve replacement segment held the largest market share at 46.9%, a trend expected to persist in subsequent years. This procedure involves the removal of a damaged valve and its replacement with a new aortic valve, which can be made from synthetic materials or animal tissues. Such procedures are crucial for restoring normal blood flow, extending patient life expectancy, and preserving heart muscle function. The advantages offered by these procedures are likely to ensure the segment's continued dominance in the market.
The surgical aortic valve replacement market was valued at US$ 3,005.9 million in 2017 and is projected to grow at a CAGR of 10.7% from 2017 to 2025, reaching US$ 6,585.8 million by 2025.
Key sources of information for this report include reputable organizations such as the Centers for Disease Control and Prevention (CDC), European Society of Cardiology, Dubai Health Authority (DHA), Health Authority of Abu Dhabi (HAAD), and the World Health Organization (WHO), among others.